| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Geographic Distribution, Foreign | 56.6 | | | | | | | |
| One Customer | 74.3 | | | | | | | |
| Medical | 286.2 | 132.5 | 120.3 | 128.9 | 110.3 | 70.1 | 64.7 | 57.3 |
| Other | | 73.8 | 59.1 | 69.5 | 80.2 | 77.8 | 81.4 | 81.6 |
| Total revenues | 353.8 | 206.3 | 179.4 | 198.4 | 190.5 | 147.8 | 146.1 | 138.9 |
| Revenue growth [+] | 71.5% | 15.0% | -9.6% | 4.2% | 28.8% | 1.2% | 5.2% | -0.3% |
| Medical | 116.0% | 10.2% | -6.7% | 16.9% | 57.3% | 8.3% | 13.0% | 14.4% |
| Automotive | 12.1% | 6.8% | -27.0% | -0.1% | -13.4% | -15.2% | 1.4% | -1.8% |
| Cost of goods sold | 263.5 | 155.2 | 134.7 | 144.4 | 142.1 | 112.4 | 111.5 | 101.4 |
| Gross profit | 90.3 | 51.1 | 44.7 | 54.0 | 48.3 | 35.5 | 34.7 | 37.5 |
| Gross margin | 25.5% | 24.8% | 24.9% | 27.2% | 25.4% | 24.0% | 23.7% | 27.0% |
| Selling, general and administrative | 45.8 | 29.5 | 27.5 | 29.3 | 27.7 | 23.7 | 24.1 | 24.0 |
| Equity in earnings | | | | | | | | |
| Other operating expenses | 19.7 | | | | | | | |
| EBITDA [+] | 36.7 | 30.0 | 25.5 | 32.9 | 28.5 | 17.4 | 16.2 | 18.3 |
| EBITDA growth | 22.1% | 18.0% | -22.6% | 15.4% | 63.7% | 7.5% | -11.6% | 0.1% |
| EBITDA margin | 10.4% | 14.6% | 14.2% | 16.6% | 15.0% | 11.8% | 11.1% | 13.2% |
| Depreciation | 7.5 | 7.1 | 7.0 | 6.9 | 6.6 | 5.3 | 5.3 | 4.5 |
| EBITA | 29.2 | 22.9 | 18.5 | 26.0 | 21.9 | 12.1 | 10.8 | 13.8 |
| EBITA margin | 8.3% | 11.1% | 10.3% | 13.1% | 11.5% | 8.2% | 7.4% | 9.9% |
| Amortization of intangibles | 4.4 | 1.3 | 1.3 | 1.3 | 1.2 | 0.3 | 0.3 | 0.3 |
| EBIT [+] | 24.8 | 21.6 | 17.2 | 24.7 | 20.7 | 11.8 | 10.5 | 13.4 |
| EBIT growth | 14.6% | 25.8% | -30.4% | 19.6% | 75.6% | 11.6% | -21.6% | -3.2% |
| EBIT margin | 7.0% | 10.5% | 9.6% | 12.5% | 10.8% | 8.0% | 7.2% | 9.7% |
| Non-recurring items [+] | -30.6 | 0.4 | 0.5 | | 1.0 | 0.1 | -1.7 | 1.7 |
| Loss (gain) on sale of assets | -6.1 | 0.0 | 0.5 | | 0.0 | 0.0 | 0.0 | 0.0 |
| Loss (gain) on sale of business | -15.7 | | | | | | | |
| Legal settlement | | | | | | | -2.1 | |
| Loss on contingent liability | -9.8 | | | | | | | |
| Interest expense, net [+] | 2.8 | 0.0 | 0.1 | 0.7 | 1.3 | -0.2 | -0.1 | 0.0 |
| Interest expense | 2.8 | 0.0 | 0.1 | 0.7 | 1.3 | 0.1 | 0.1 | 0.1 |
| Interest income | | | | | 0.0 | 0.2 | 0.1 | 0.1 |
| Other income (expense), net | 0.1 | 0.0 | -0.4 | -0.4 | 0.1 | | | |
| Pre-tax income | 52.7 | 21.2 | 16.3 | 23.6 | 18.4 | 11.9 | 12.3 | 11.7 |
| Income taxes | 10.9 | 5.3 | 2.9 | 3.9 | 4.1 | 2.6 | 4.3 | 4.1 |
| Tax rate | 20.7% | 25.1% | 17.9% | 16.5% | 22.2% | 22.3% | 35.3% | 35.3% |
| Net income | 41.8 | 15.9 | 13.4 | 19.8 | 14.3 | 9.2 | 8.0 | 7.6 |
| Net margin | 11.8% | 7.7% | 7.5% | 10.0% | 7.5% | 6.2% | 5.5% | 5.5% |
| |
| Basic EPS [+] | $5.52 | $2.11 | $1.79 | $2.66 | $1.95 | $1.27 | $1.11 | $1.07 |
| Growth | 161.7% | 18.2% | -32.9% | 36.6% | 53.3% | 14.6% | 3.7% | -0.6% |
| Diluted EPS [+] | $5.45 | $2.09 | $1.77 | $2.63 | $1.93 | $1.26 | $1.10 | $1.05 |
| Growth | 161.4% | 18.1% | -32.8% | 36.4% | 53.4% | 14.6% | 4.0% | 0.0% |
| |
| Shares outstanding (basic) [+] | 7.6 | 7.5 | 7.5 | 7.4 | 7.3 | 7.2 | 7.2 | 7.1 |
| Growth | 0.5% | 0.5% | 0.8% | 1.0% | 1.4% | 0.8% | 1.2% | 1.1% |
| Shares outstanding (diluted) [+] | 7.7 | 7.6 | 7.6 | 7.5 | 7.4 | 7.3 | 7.3 | 7.2 |
| Growth | 0.6% | 0.6% | 0.7% | 1.2% | 1.3% | 0.9% | 1.0% | 0.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |